查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2139922

Altrenogest動物用藥品市場：全球市場預測，2026-2032年

Altrenogest Veterinary Drug Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，阿特諾孕酮動物用藥品市場將成長至 2.8543 億美元，複合年成長率為 16.25%。

主要市場統計數據
基準年 2025 9947萬美元
預計年份：2026年 1.1482億美元
預測年份 2032 2.8543億美元
複合年成長率 (%) 16.25%

獸用阿特諾動物醫藥：概述

阿特諾孕酮是一種合成孕激素，主要用於獸醫繁殖管理，尤其是在豬（在某些地區也用於馬）中，用於支持發情同步和計劃配種。其實際價值在於制定更可預測的配種計劃，提高工作協調效率，並促進育種計劃與畜群管理系統的更緊密結合。其使用需要獸醫監督，並受限於目標動物種類、停藥期要求以及遵守國家批准法規。

育種管理正變得越來越系統化和數據驅動。

在獸醫生產系統中，精準育種、動物福利、可追溯性和合理用藥的重要性日益凸顯。這些優先事項促使生產者和獸醫將荷爾蒙療法方案與發情檢測、配種時間、身體狀況、胎次、健康狀況和生產力記錄相結合。因此，是否實施這些方案不僅取決於其藥理效果，還取決於其易於實施、人員培訓、法規遵循以及與農場管理軟體和操作流程的兼容性。

人工智慧可以提高時間把控、監控和合規性。

人工智慧 (AI) 可透過分析活動、飼餵、繁殖和健康記錄來支持與阿特諾孕酮相關的項目，從而識別需要關注的個體並確保周密的治療計劃管理。電腦視覺和感測器系統可以輔助發情觀察，並幫助檢測與預期反應的偏差，而電子記錄可以指出漏服的劑量、未完成的療程和不完整的文件。這些工具是對獸醫判斷的補充，而非替代，因為數據品質、生物變異性、已批准標籤的限制以及動物福利方面的考慮仍然是至關重要的因素。

區域見解：法規、生產系統和獸醫服務因地區而異。

在北美，受監管的獸藥通路與技術先進的畜牧養殖實踐相結合，並高度重視殘留物控制和記錄。拉丁美洲擁有重要的畜牧和生豬生產中心，但各國在進入、進口限制和獸醫基礎設施方面存在差異。在歐洲，動物福利、可追溯性、合理使用抗生素以及協調一致且不斷發展的監管要求至關重要。中東的特點是依賴進口、獨特的生產系統以及獸醫系統的區域差異，而非洲在商業活動、診斷和藥品分銷方面則表現出顯著差異。亞太地區擁有規模龐大且高度多樣化的畜牧系統，其實施受到疾病控制重點、監管現代化和商業性畜牧養殖規模的影響。

區域洞察：貿易、監管和生產網路塑造使用情況

在東協市場，由於核准流程、獸醫服務覆蓋範圍和畜牧業結構各不相同，本地註冊和經銷商能力至關重要。金磚國家擁有主要的農業體系，但在監管執法、生產標準化和生殖專家服務方面有顯著差異。歐盟的特點是擁有協調一致的法律規範、嚴格的食品安全標準和對動物福利的嚴格監管。七國集團（G7）國家通常擁有成熟的獸醫基礎設施和先進的可追溯性要求。海灣合作理事會（GCC）國家往往依賴進口動物用藥品和專業獸醫服務，而北約成員國則擁有多元化的生產環境，並透過大規模的貿易和監管合作緊密聯繫在一起。

國家概況：國內法規與生產環境決定產品採用情況

澳洲重視獸醫監管、生物安全和牲畜可追溯性。巴西兼具大規模畜牧養殖和區域差異較大的法規及分銷條件。加拿大和美國已建立系統化的獸醫通路，並密切關注殘留物、標籤和生產者記錄。中國和印度的生產環節多樣，涵蓋大規模商業性營運到小規模農場，因此實施需求也各不相同。日本和韓國重視受控生產、食品安全和技術控制。法國、德國、義大利和西班牙在歐洲監管和動物福利框架內運作，國家層級的獸醫實踐影響著應用案例。英國對藥品可追溯性有嚴格的管治和要求。墨西哥的生產基礎多元化，獸醫資源的可近性、進口要求和生產者教育程度都會影響其應用。俄羅斯的法規環境、國內供應情況以及區域生產差異是參與企業俄羅斯市場時需要考慮的重要因素。

產業重點：建立符合監管規定、資料支援的育種計畫。

產業領導者必須確保所有方案均符合現行的國家核准標準、目標物種標籤、獸醫指導、藥物停藥期和記錄保存要求。他們還應投資於員工培訓、標準化管理流程、治療檢驗以及基於生育力、動物健康和福利指標的療效追蹤。與獸醫、診斷服務提供者、數位化管理專家和合格的分銷管道建立合作關係有助於提升方案的實施效果。此外，領導者還應制定緊急時應對計畫以應對供應中斷，定期審查育種結果，並僅在數據檢驗、管治透明且有人工監督的情況下使用人工智慧。

調查方法：基於證據的獸醫用途評估

本執行摘要聚焦於「阿特諾孕酮（動物醫藥）」這個主題，並圍繞獸用用途、監管環境、生產系統特徵、數位轉型和地理背景等維度對研究結果進行梳理。本評估區分了既有用途和新興用途，避免了未經證實的量化論斷，並將區域、集團和國家層面的情況視為異質性因素。在做出任何操作決策之前，應根據當前產品標籤、國家動物醫藥資料庫、官方食品安全要求、同行檢驗文獻以及相關獸醫權威機構的指導意見，對本報告的解讀進行核實。

結論：負責任的整合有助於提高生殖保健的準確性。

在獸醫的監督下，並嚴格遵守明確的監管和福利要求，使用阿特諾孕酮進行繁殖管理最為有效。最有效的操作方法是將合適的產品選擇與準確的動物記錄、訓練有素的負責人、嚴格的管理以及結果監測相結合。雖然需要製定本地化的合規和實施策略來應對區域和國家差異，但如果將人工智慧作為一種輔助決策的功能來實施，而不是替代專家獸醫的評估，則有助於提高透明度和及時性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：阿特諾動物用藥品市場：依動物類型分類

  • 牛
    • 牛肉
    • 乳牛
  • 馬
    • 種馬
    • 比賽用馬
  • 豬
    • 未繁殖的豬
    • 母豬

第8章：獸用阿特諾動物用藥品市場：以劑型分類

  • 注射藥物
  • 口服液體藥物
  • 口服粉劑

第9章：阿特諾動物用藥品市場：依應用領域分類

  • 發情同步
    • 長期方案
    • 短協議
  • 育種管理

第10章：阿特諾動物用藥品市場：依最終用戶分類

  • 農場
    • 商業農場
    • 小規模農場
  • 網路藥房
  • 動物醫院

第11章：阿特諾動物用藥品市場：依分銷管道分類

  • 線上
  • 離線

第12章：阿特諾動物用藥品市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：阿特諾動物用藥品市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：阿特諾動物用藥品市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Animalcare Group plc
  • Bimeda Animal Health
  • Boehringer Ingelheim Vetmedica GmbH
  • Ceva Sante Animale
  • Chanelle Pharma Group Ltd.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Henry Schein Animal Health
  • Huvepharma Inc.
  • Kyoritsu Seiyaku Corporation
  • Merck & Co., Inc.
  • MWI Animal Health
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Phibro Animal Health Corporation
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.

第17章 主要專家

Product Code: MRR-9C4233EE5B13

The Altrenogest Veterinary Drug Market is projected to grow by USD 285.43 million at a CAGR of 16.25% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 99.47 million
Estimated Year [2026] USD 114.82 million
Forecast Year [2032] USD 285.43 million
CAGR (%) 16.25%

Altrenogest Veterinary Drug: Executive Overview

Altrenogest is a synthetic progestogen used primarily in veterinary reproductive management, particularly to help synchronize estrus and support planned breeding in swine and, in some jurisdictions, horses. Its practical value is linked to more predictable breeding schedules, improved labor coordination, and tighter integration of reproductive programs with herd-management systems. Use is subject to veterinary oversight, animal-species restrictions, withdrawal requirements, and national authorization rules.

Reproductive Management Is Becoming More Structured and Data-Led

Veterinary production systems are increasingly emphasizing reproductive precision, animal welfare, traceability, and responsible medicine use. These priorities are encouraging producers and veterinarians to combine hormonal protocols with records on estrus detection, breeding timing, body condition, parity, health status, and productivity. Adoption decisions therefore depend not only on pharmacological performance but also on protocol simplicity, staff training, regulatory compliance, and compatibility with farm-management software and operating procedures.

Artificial Intelligence Strengthens Timing, Monitoring, and Compliance

Artificial intelligence can support altrenogest-related programs by analyzing activity, feeding, reproductive, and health records to identify animals requiring attention and to improve scheduling discipline. Computer vision and sensor systems may assist estrus observation and detect deviations from expected responses, while digital records can flag missed administrations, incomplete treatment courses, and documentation gaps. These tools complement rather than replace veterinary judgment, because data quality, biological variation, approved-label constraints, and animal-welfare considerations remain decisive.

Regional Insights: Regulation, Production Systems, and Veterinary Access Differ

North America combines regulated veterinary medicine channels with technologically advanced livestock operations and strong emphasis on residue control and documentation. Latin America has important livestock and swine production bases, but access, import rules, and veterinary infrastructure vary across countries. Europe places substantial weight on animal welfare, traceability, antimicrobial stewardship, and harmonized yet evolving regulatory requirements. The Middle East is shaped by import dependence, specialized production systems, and differing veterinary capacities, while Africa reflects wide variation in commercial intensity, diagnostic access, and medicine distribution. Asia-Pacific includes large and highly diverse animal-production systems, with adoption conditions influenced by disease-control priorities, regulatory modernization, and the scale of commercial farming.

Group Insights: Trade, Regulation, and Production Networks Shape Use

ASEAN markets show differing approval pathways, veterinary-service coverage, and livestock structures, making local registration and distributor capability important. BRICS members span major agricultural systems but differ considerably in regulatory enforcement, production formalization, and access to reproductive specialists. The European Union is characterized by coordinated regulatory frameworks, strict food-safety expectations, and strong welfare scrutiny. G7 countries generally have mature veterinary infrastructure and sophisticated traceability requirements. GCC countries often rely on imported animal-health products and specialized veterinary services, while NATO members represent diverse production environments connected by substantial trade and regulatory cooperation.

Country Insights: National Rules and Production Context Drive Adoption

Australia emphasizes veterinary oversight, biosecurity, and livestock traceability. Brazil combines large-scale animal production with regionally varied regulatory and distribution conditions. Canada and the United States have structured veterinary channels and strong attention to residues, labeling, and producer records. China and India contain diverse production segments, ranging from highly commercial operations to smaller farms, creating varied implementation needs. Japan and South Korea emphasize controlled production, food safety, and technical management. France, Germany, Italy, and Spain operate within European regulatory and welfare frameworks, with country-level veterinary practice shaping use. The United Kingdom maintains stringent medicine governance and traceability expectations. Mexico reflects a mixed production base in which veterinary access, import requirements, and producer education influence deployment. Russia's regulatory environment, domestic supply considerations, and regional production differences are important factors for market participation.

Industry Priorities: Build Compliant, Data-Supported Reproductive Programs

Industry leaders should align every protocol with current national authorization, species labeling, veterinary direction, withdrawal periods, and recordkeeping obligations. They should invest in staff training, standardized administration procedures, treatment verification, and outcome tracking based on fertility, animal health, and welfare indicators. Partnerships with veterinarians, diagnostic providers, digital-management specialists, and qualified distribution channels can improve implementation. Leaders should also maintain contingency plans for supply disruption, conduct periodic reviews of reproductive outcomes, and use artificial intelligence only with validated data, transparent governance, and human oversight.

Research Methodology: Evidence-Based Assessment of Veterinary Use

This executive summary uses the defined topic-altrenogest veterinary drug-as its analytical scope and organizes findings around veterinary applications, regulatory conditions, production-system characteristics, digital transformation, and geographic context. The assessment distinguishes established applications from emerging capabilities, avoids unsupported quantitative claims, and treats regional, group, and country conditions as heterogeneous. Interpretation should be validated against current product labels, national veterinary-medicine databases, official food-safety requirements, peer-reviewed literature, and guidance from competent veterinary authorities before operational decisions are made.

Conclusion: Responsible Integration Supports Reproductive Precision

Altrenogest remains most relevant where planned reproductive management can be implemented under veterinary supervision and within clearly defined regulatory and welfare requirements. The strongest operational approach combines appropriate product selection with accurate animal records, trained personnel, disciplined administration, and outcome monitoring. Regional and national differences require localized compliance and delivery strategies, while artificial intelligence can improve visibility and timing when deployed as a controlled decision-support capability rather than a substitute for professional veterinary assessment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Altrenogest Veterinary Drug Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Cattle
    • 7.2.1. Beef
    • 7.2.2. Dairy
  • 7.3. Equine
    • 7.3.1. Breeding Horses
    • 7.3.2. Performance Horses
  • 7.4. Swine
    • 7.4.1. Gilts
    • 7.4.2. Sows

8. Altrenogest Veterinary Drug Market, by Form

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral Liquid
  • 8.4. Oral Powder

9. Altrenogest Veterinary Drug Market, by Application

  • 9.1. Introduction
  • 9.2. Estrus Synchronization
    • 9.2.1. Long Protocols
    • 9.2.2. Short Protocols
  • 9.3. Reproductive Management

10. Altrenogest Veterinary Drug Market, by End User

  • 10.1. Introduction
  • 10.2. Farms
    • 10.2.1. Commercial Farms
    • 10.2.2. Smallholder Farms
  • 10.3. Online Pharmacies
  • 10.4. Veterinary Hospitals

11. Altrenogest Veterinary Drug Market, by Distribution Channel

  • 11.1. Introduction
  • 11.2. Online
  • 11.3. Offline

12. Altrenogest Veterinary Drug Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Altrenogest Veterinary Drug Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Altrenogest Veterinary Drug Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Animalcare Group plc
  • 16.2. Bimeda Animal Health
  • 16.3. Boehringer Ingelheim Vetmedica GmbH
  • 16.4. Ceva Sante Animale
  • 16.5. Chanelle Pharma Group Ltd.
  • 16.6. Dechra Pharmaceuticals PLC
  • 16.7. Elanco Animal Health Incorporated
  • 16.8. Henry Schein Animal Health
  • 16.9. Huvepharma Inc.
  • 16.10. Kyoritsu Seiyaku Corporation
  • 16.11. Merck & Co., Inc.
  • 16.12. MWI Animal Health
  • 16.13. Neogen Corporation
  • 16.14. Norbrook Laboratories Ltd.
  • 16.15. Phibro Animal Health Corporation
  • 16.16. Vetoquinol S.A.
  • 16.17. Virbac S.A.
  • 16.18. Zoetis Inc.

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Altrenogest Veterinary Drug Market, Years Considered for the Study
  • FIGURE 2. Global Altrenogest Veterinary Drug Market, Research Design
  • FIGURE 3. Global Altrenogest Veterinary Drug Market, Research Framework
  • FIGURE 4. Global Altrenogest Veterinary Drug Market, Data Triangulation
  • FIGURE 5. Global Altrenogest Veterinary Drug Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Altrenogest Veterinary Drug Market Size, by Animal Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Altrenogest Veterinary Drug Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Altrenogest Veterinary Drug Market Size, by Form, 2025 vs 2032 (%)
  • FIGURE 9. Global Altrenogest Veterinary Drug Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Altrenogest Veterinary Drug Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 11. Global Altrenogest Veterinary Drug Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Altrenogest Veterinary Drug Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 13. Global Altrenogest Veterinary Drug Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 15. Global Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Altrenogest Veterinary Drug Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Altrenogest Veterinary Drug Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Altrenogest Veterinary Drug Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Altrenogest Veterinary Drug Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Altrenogest Veterinary Drug Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Altrenogest Veterinary Drug Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Altrenogest Veterinary Drug Market Segmentation & Coverage
  • TABLE 2. Global Altrenogest Veterinary Drug Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 4. Global Cattle Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Cattle Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Cattle Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Beef Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Beef Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Beef Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Dairy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Dairy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Dairy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Equine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Equine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Equine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Breeding Horses Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Breeding Horses Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Breeding Horses Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Performance Horses Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Performance Horses Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Performance Horses Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Swine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Swine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Swine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Gilts Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Gilts Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Gilts Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Sows Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Sows Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Sows Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 32. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global Oral Liquid Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global Oral Liquid Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global Oral Liquid Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global Oral Powder Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 39. Global Oral Powder Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 40. Global Oral Powder Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 41. Global Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 42. Global Estrus Synchronization Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global Estrus Synchronization Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global Estrus Synchronization Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Long Protocols Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Long Protocols Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Long Protocols Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global Short Protocols Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 49. Global Short Protocols Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 50. Global Short Protocols Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 51. Global Reproductive Management Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Global Reproductive Management Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 53. Global Reproductive Management Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 54. Global Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 55. Global Farms Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Global Farms Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 57. Global Farms Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 58. Global Commercial Farms Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Global Commercial Farms Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 60. Global Commercial Farms Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 61. Global Smallholder Farms Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Global Smallholder Farms Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 63. Global Smallholder Farms Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 64. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 65. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 66. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 67. Global Veterinary Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 68. Global Veterinary Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 69. Global Veterinary Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 70. Global Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 71. Global Online Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 72. Global Online Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 73. Global Online Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 74. Global Offline Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 75. Global Offline Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 76. Global Offline Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 77. Global Altrenogest Veterinary Drug Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Asia-Pacific Altrenogest Veterinary Drug Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 79. Asia-Pacific Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 80. Asia-Pacific Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 81. Asia-Pacific Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 82. Asia-Pacific Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 83. Asia-Pacific Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 84. Asia-Pacific Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 85. Asia-Pacific Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 86. Asia-Pacific Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 87. Asia-Pacific Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 88. Asia-Pacific Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 89. North America Altrenogest Veterinary Drug Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 90. North America Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 91. North America Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 92. North America Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 93. North America Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 94. North America Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 95. North America Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 96. North America Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 97. North America Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 98. North America Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 99. North America Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 100. Latin America Altrenogest Veterinary Drug Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 101. Latin America Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 102. Latin America Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 103. Latin America Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 104. Latin America Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 105. Latin America Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 106. Latin America Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 107. Latin America Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 108. Latin America Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 109. Latin America Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 110. Latin America Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 111. Europe Altrenogest Veterinary Drug Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 112. Europe Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 113. Europe Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 114. Europe Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 115. Europe Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 116. Europe Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 117. Europe Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 118. Europe Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 119. Europe Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 120. Europe Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 121. Europe Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 122. Middle East Altrenogest Veterinary Drug Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 123. Middle East Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 124. Middle East Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 125. Middle East Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 126. Middle East Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 127. Middle East Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 128. Middle East Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 129. Middle East Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 130. Middle East Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 131. Middle East Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 132. Middle East Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 133. Africa Altrenogest Veterinary Drug Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 134. Africa Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 135. Africa Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 136. Africa Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 137. Africa Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 138. Africa Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 139. Africa Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 140. Africa Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 141. Africa Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 142. Africa Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 143. Africa Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 144. Global Altrenogest Veterinary Drug Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 145. ASEAN Altrenogest Veterinary Drug Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 146. ASEAN Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 147. ASEAN Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 148. ASEAN Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 149. ASEAN Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 150. ASEAN Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 151. ASEAN Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 152. ASEAN Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 153. ASEAN Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 154. ASEAN Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 155. ASEAN Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 156. GCC Altrenogest Veterinary Drug Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 157. GCC Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 158. GCC Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 159. GCC Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 160. GCC Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 161. GCC Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 162. GCC Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 163. GCC Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 164. GCC Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 165. GCC Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 166. GCC Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 167. European Union Altrenogest Veterinary Drug Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 168. European Union Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 169. European Union Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 170. European Union Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 171. European Union Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 172. European Union Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 173. European Union Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 174. European Union Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 175. European Union Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 176. European Union Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 177. European Union Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 178. BRICS Altrenogest Veterinary Drug Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 179. BRICS Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 180. BRICS Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 181. BRICS Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 182. BRICS Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 183. BRICS Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 184. BRICS Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 185. BRICS Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 186. BRICS Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 187. BRICS Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 188. BRICS Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 189. G7 Altrenogest Veterinary Drug Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 190. G7 Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 191. G7 Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 192. G7 Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 193. G7 Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 194. G7 Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 195. G7 Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 196. G7 Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 197. G7 Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 198. G7 Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 199. G7 Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 200. NATO Altrenogest Veterinary Drug Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 201. NATO Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 202. NATO Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 203. NATO Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 204. NATO Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 205. NATO Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 206. NATO Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 207. NATO Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 208. NATO Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 209. NATO Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 210. NATO Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 211. Global Altrenogest Veterinary Drug Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 212. United States Altrenogest Veterinary Drug Market Size, 2017-2032 (USD Million)
  • TABLE 213. United States Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 214. United States Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 215. United States Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 216. United States Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 217. United States Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 218. United States Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 219. United States Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 220. United States Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 221. United States Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 222. United States Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 223. Canada Altrenogest Veterinary Drug Market Size, 2017-2032 (USD Million)
  • TABLE 224. Canada Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 225. Canada Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 226. Canada Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 227. Canada Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 228. Canada Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 229. Canada Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 230. Canada Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 231. Canada Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 232. Canada Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 233. Canada Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 234. Mexico Altrenogest Veterinary Drug Market Size, 2017-2032 (USD Million)
  • TABLE 235. Mexico Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 236. Mexico Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 237. Mexico Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 238. Mexico Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 239. Mexico Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 240. Mexico Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 241. Mexico Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 242. Mexico Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 243. Mexico Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 244. Mexico Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 245. Brazil Altrenogest Veterinary Drug Market Size, 2017-2032 (USD Million)
  • TABLE 246. Brazil Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 247. Brazil Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 248. Brazil Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 249. Brazil Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 250. Brazil Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 251. Brazil Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 252. Brazil Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 253. Brazil Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 254. Brazil Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 255. Brazil Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 256. United Kingdom Altrenogest Veterinary Drug Market Size, 2017-2032 (USD Million)
  • TABLE 257. United Kingdom Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 258. United Kingdom Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 259. United Kingdom Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 260. United Kingdom Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 261. United Kingdom Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 262. United Kingdom Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 263. United Kingdom Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 264. United Kingdom Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 265. United Kingdom Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 266. United Kingdom Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 267. Germany Altrenogest Veterinary Drug Market Size, 2017-2032 (USD Million)
  • TABLE 268. Germany Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 269. Germany Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 270. Germany Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 271. Germany Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 272. Germany Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 273. Germany Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 274. Germany Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 275. Germany Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 276. Germany Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 277. Germany Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 278. France Altrenogest Veterinary Drug Market Size, 2017-2032 (USD Million)
  • TABLE 279. France Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 280. France Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 281. France Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 282. France Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 283. France Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 284. France Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 285. France Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 286. France Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 287. France Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 288. France Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 289. Russia Altrenogest Veterinary Drug Market Size, 2017-2032 (USD Million)
  • TABLE 290. Russia Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 291. Russia Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 292. Russia Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 293. Russia Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 294. Russia Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 295. Russia Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 296. Russia Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 297. Russia Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 298. Russia Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 299. Russia Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 300. Italy Altrenogest Veterinary Drug Market Size, 2017-2032 (USD Million)
  • TABLE 301. Italy Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 302. Italy Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 303. Italy Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 304. Italy Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 305. Italy Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 306. Italy Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 307. Italy Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 308. Italy Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 309. Italy Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 310. Italy Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 311. Spain Altrenogest Veterinary Drug Market Size, 2017-2032 (USD Million)
  • TABLE 312. Spain Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 313. Spain Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 314. Spain Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 315. Spain Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 316. Spain Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 317. Spain Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 318. Spain Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 319. Spain Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 320. Spain Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 321. Spain Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 322. China Altrenogest Veterinary Drug Market Size, 2017-2032 (USD Million)
  • TABLE 323. China Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 324. China Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 325. China Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 326. China Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 327. China Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 328. China Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 329. China Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 330. China Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 331. China Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 332. China Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 333. India Altrenogest Veterinary Drug Market Size, 2017-2032 (USD Million)
  • TABLE 334. India Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 335. India Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 336. India Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 337. India Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 338. India Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 339. India Altrenogest Veterinary Drug Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 340. India Altrenogest Veterinary Drug Market Size, by Estrus Synchronization, 2017-2032 (USD Million)
  • TABLE 341. India Altrenogest Veterinary Drug Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 342. India Altrenogest Veterinary Drug Market Size, by Farms, 2017-2032 (USD Million)
  • TABLE 343. India Altrenogest Veterinary Drug Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 344. Japan Altrenogest Veterinary Drug Market Size, 2017-2032 (USD Million)
  • TABLE 345. Japan Altrenogest Veterinary Drug Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 346. Japan Altrenogest Veterinary Drug Market Size, by Cattle, 2017-2032 (USD Million)
  • TABLE 347. Japan Altrenogest Veterinary Drug Market Size, by Equine, 2017-2032 (USD Million)
  • TABLE 348. Japan Altrenogest Veterinary Drug Market Size, by Swine, 2017-2032 (USD Million)
  • TABLE 349. Japan Altrenogest Veterinary Drug Market Size, by Form, 2017-2032 (USD Million)
  • TABLE 350. Japa